CST3 and sarcopenia: Also, in contrast to other studies, OPRA includes information on sarcopenia and glucocorticoid treatment, two significant non-renal factors affecting creatinine and cystatin C and which allows us to establish an accurate picture of eGFRcysC/eGFRcrea ratio in the general elderly population.